Skip to main content
Porto

Main navigation

  • Home
  • PMMNG Meetings
    • PMMNG Monthly Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma 5K
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

belantamab mafodotin

MMRF logoWhat:  Webcast
When: Tuesday, November 17, 2020 100 PM – 2:00 PM ET
Where: Web
View slides

Tags
event
archived
webcast
mmrf
treatment
newly approved drugs
blenrep
belantamab mafodotin
xpovio
selinexor
darzalex faspro
daratumumab and hyaluronidase
sarclisa
isatuximab
Dr. Joshua R. Richter
Dr. Nina Shah
  • Read more about MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma
Subscribe to belantamab mafodotin